PON1Q192R polymorphism is associated with lipid profile in Mexican men with Mayan ascendancy (Q46517224)

22 December 2017

title

PON1Q192R polymorphism is associated with lipid profile in Mexican men with Mayan ascendancy (English)

1 reference

22 December 2017

author name string

Norma Pérez-Herrera

1

1 reference

22 December 2017

Carlos May-Pech

2

1 reference

22 December 2017

Isabel Hernández-Ochoa

3

1 reference

22 December 2017

Jorge Castro-Mañé

4

1 reference

22 December 2017

Elizabeth Rojas-García

5

1 reference

22 December 2017

Víctor Hugo Borja-Aburto

6

1 reference

22 December 2017

Teresa Castillo-Burguete

7

1 reference

22 December 2017

Betzabet Quintanilla-Vega

8

1 reference

22 December 2017

publication date

4 June 2008

1 reference

22 December 2017

Experimental and Molecular Pathology

published in

1 reference

22 December 2017

volume

85

1 reference

22 December 2017

page(s)

129-134

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

DNA Polymorphisms of the Apolipoprotein AI/CIII/ AIV Gene Cluster Influence Plasma Cholesterol and Triglyceride Levels in the Mayans of the Yucat&aacute;n Peninsula, Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Increased influence of genetic variation on PON1 activity in neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Polymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Paraoxonase and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Association between PON1 L/M55 polymorphism and plasma lipoproteins in two Canadian aboriginal populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Distribution of paraoxonase PON1 gene polymorphisms in Mexican populations. Its role in the lipid profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

A study of the polymorphism and ethnic distribution differences of human serum paraoxonase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Polymorphic Alu insertions among Mayan populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

The PON1192RR genotype is associated with a higher prevalence of arterial hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Genetic polymorphisms and activity of PON1 in a Mexican population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Effect of physical activity on lipid levels in a population-based sample of men with and without the Arg192 variant of the human paraoxonase gene

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

inferred from DOI database lookup

7 January 2021

based on heuristic

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Interaction between the Gln-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high-density lipoprotein cholesterol and paraoxonase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.05.003

10.1016/J.YEXMP.2008.05.003

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

18582459

1 reference

22 December 2017